June 17, 2020 / 11:47 AM / 17 days ago

BRIEF-Inflarx Reports Topline Results From Exploratory Phase II Part Of Adaptive Randomized Phase II/III Trial Of IFX-1 In Covid-19

June 17 (Reuters) - Inflarx NV:

* INFLARX REPORTS ENCOURAGING TOPLINE RESULTS FROM THE EXPLORATORY PHASE II PART OF THE ADAPTIVE RANDOMIZED PHASE II/III TRIAL OF IFX-1 IN COVID-19

* INFLARX - INDEPENDENT DATA SAFETY MONITORING BOARD RECOMMENDED CONTINUATION OF TRIAL INTO PHASE III PART Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below